Search company, investor...

Predict your next investment

GeneChem Therapeutics Venture Fund company logo
Venture Capital

Investments

5

Portfolio Exits

1

About GeneChem Therapeutics Venture Fund

GeneChem Therapeutics Venture Fund focuses on the management of biotechnology venture capital funds, operating within the biotechnology and investment sectors. The company's main service is investing in businesses involved in drug discovery and development. The primary sectors are the biotechnology and pharmaceutical industries. It is based in Montreal, Canada.

Headquarters Location

1 Westmount Square Suite 800

Montreal, Quebec, H3Z 2P9,

Canada

514-849-7696

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

GeneChem Therapeutics Venture Fund Investments

5 Investments

GeneChem Therapeutics Venture Fund has made 5 investments. Their latest investment was in CoImmune as part of their Debt - III on July 7, 2011.

CBI Logo

GeneChem Therapeutics Venture Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/22/2011

Debt - III

CoImmune

$3.5M

No

9/13/2010

Debt - II

Subscribe to see more

$99M

Subscribe to see more

0

11/21/2008

Series C - II

Subscribe to see more

$99M

Subscribe to see more

0

4/14/2008

Series C

Subscribe to see more

Subscribe to see more

0

9/19/2001

Series B

Subscribe to see more

$99M

Subscribe to see more

0

Date

7/22/2011

9/13/2010

11/21/2008

4/14/2008

9/19/2001

Round

Debt - III

Debt - II

Series C - II

Series C

Series B

Company

CoImmune

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$3.5M

$99M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

0

0

0

0

GeneChem Therapeutics Venture Fund Portfolio Exits

1 Portfolio Exit

GeneChem Therapeutics Venture Fund has 1 portfolio exit. Their latest portfolio exit was CoImmune on February 07, 2014.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/7/2014

IPO

$99M

Public

3

Date

2/7/2014

Exit

IPO

Companies

Valuation

$99M

Acquirer

Public

Sources

3

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.